Citius Oncology (CTOR)

• Market cap: $120M
• 1 day: -6.49%
• 5 days: -18.18%
• 1 month: -22.99%
• 3 months: -24.61%
• 6 months: 65.75%
• Year to date: 21.01%
• 1 year: 22.03%
• 5 years: -85.73%
• 10 years: -85.73%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.